[Hemiballism-hemichorea syndrome].
Wehrschuetz
M
M
Simbrunner
J
J
Enzinger
C
C
Ebner
F
F
D018726:Anti-Dyskinesia Agents / Q000008:administration & dosage / Q000627:therapeutic use; D001927:Brain Diseases / Q000175:diagnosis* / Q000000981:diagnostic imaging; D002560:Cerebrovascular Circulation; D002819:Chorea / Q000150:complications / Q000175:diagnosis / Q000209:etiology*; D004359:Drug Therapy, Combination; D020820:Dyskinesias / Q000150:complications / Q000175:diagnosis / Q000209:etiology*; D005500:Follow-Up Studies; D006442:Glycated Hemoglobin / Q000032:analysis; D006220:Haloperidol / Q000008:administration & dosage / Q000627:therapeutic use; D006801:Humans; D006943:Hyperglycemia / Q000150:complications* / Q000503:physiopathology; D008140:Lorazepam / Q000008:administration & dosage / Q000627:therapeutic use; D008279:Magnetic Resonance Imaging; D008297:Male; D008875:Middle Aged; D011699:Putamen / Q000000981:diagnostic imaging / Q000473:pathology*; D013577:Syndrome; D013997:Time Factors; D014057:Tomography, X-Ray Computed; D016896:Treatment Outcome
D018726:Anti-Dyskinesia Agents; D006442:Glycated Hemoglobin; D006220:Haloperidol; D008140:Lorazepam